Table 1 Baseline characteristics of the study population according to HbA1c

Age (y), studies = 12, n = 10734

64

65

Male (%), studies = 12, n = 10734

64

72

History of Hypertension (%),

studies = 10, n = 10242

74

59

History of Heart failure (%),

studies = 4, n = 5276

22

14

Previous MI (%), studies = 3, n = 4219

48

24

Hyperlipidemia (%), studies = 3, n = 4149

36

35

Smoker (%), studies = 7, n = 3770

40

41

Body mass index (kg/m2), studies = 6, n = 2990

27

29

Renal insufficiency (%), studies = 5, n = 5806

10

7

β-Blocker (%), studies = 4, n = 3794

77

77

Angiotensin-converting enzyme (ACE) inhibitors (%), studies = 3, n = 1448

53

39

Lipid lowering drugs (%), studies = 4, n = 3794

67

41